Background/Aim: Percutaneous transhepatic cholangioscopy (PTCS) has been widely used for the diagnosis and treatment. PTCS-related complications (hemobilia, cholangitis, biliary tract perforations) are not infrequent. However, data on the risk factors for PTCS-related complications are limited. Therefore, we aimed to identify the risk factors for PTCS-related complications. Methods: Two hundred thirty-three patients who underwent PTCS at a single tertiary center between January 2006 and October 2014 were enrolled. After retrospectively analyzing the patients' medical records, 212 patients were enrolled and classified into two groups: 1) a complication group and 2) a non-complication group. Results: The study population comprised 112 men and 100 women, with a median age of 64.5 years. Of the 212 patients, 32 (15.1%) developed complications: 14 (6.7%) developed cholangitis, six (2.8%) developed bile duct injury, and two (0.9%) developed hemobilia. In the univariate analyses, older age, a small number of tract dilatation sessions, and computed tomography (CT) findings of liver cirrhosis and a non-dilated intrahepatic duct were risk factors for PTCS-related complications. In the multivariate analysis, older age, a small number of tract dilatation sessions, and the CT finding of a non-dilated intrahepatic duct were independent factors for predicting PTCS-related complications. Serial tract dilatations (≥2 sessions) were performed in 95 patients (44.8%), but this did not affect the complication rate. In this subgroup of patients, a short interval between sessions (≤3 days) was associated with PTCSrelated complications. Conclusions: Elderly patients and those with non-dilated intrahepatic ducts on CT need to be managed carefully. Stepwise tract dilatations and a long interval between sessions (>3 days) can help decrease PTCS-related complications.
INTRODUCTION
Percutaneous transhepatic cholangioscopy (PTCS) has been widely used for the diagnosis and treatment of intrahepatic and extrahepatic biliary disease. [1] [2] [3] [4] [5] It is particularly useful for intrahepatic stones and cholangiocarcinomas, which have a high incidence in Northeast Asia, including Korea and Japan. 3 PTCS is not straight forward to perform because it involves several stages, including a relatively long preparatory stage, and can only be carried out by experienced endoscopists. However, PTCS is difficult to replace with other procedures because it is performed in non-operable cases and in cases that cannot be treated with percutaneous transhepatic biliary drainage (PTBD) or endoscopic retrograde cholangiopancreatography.
PTCS-related complications such as hemobilia, cholangitis, and biliary tract perforations are not infrequent. However, previous studies do not provide a representative picture of PTCS-related morbidity and mortality. [6] [7] [8] [9] There are several reasons for this lack or representativeness: the available data have been limited; studies have focused only on patients with a particular condition, such as patients who underwent lithotripsy for intrahepatic stones; and the numbers of investigated patients have been limited over long study periods. One previous study showed that rapid tract dilatation was associated with an increased rate of PTCS-related complications and mortality. 10 Currently, however, the preparations for PTCS are performed empirically because there is no fixed protocol regarding elements such as the tract dilatation interval, number of dilatation sessions, and tract maturation time. Furthermore, the prediction and prevention of complications has not been possible because of the lack studies on PTCS-related complications and their risk factors. We aimed to investigate the incidence, characteristics, and risk factors of complications in patients who had undergone PTCS. Our study focused on predicting the risk of complications based on patient characteristics, CT findings, and the type of PTCS. Further, we examined the potential for preventing PTCS-related complications by adjusting the preparatory stage protocol.
METHODS

Patients
Between January 2006 and October 2014, a total of 233 patients underwent PTCS at Pusan National University Hospital. Of these patients, those who underwent PTCS (including PTBD, tract dilatation, and tract maturation) at Pusan National University Hospital were considered for inclusion in this study. Twenty-one patients were excluded: five because they were transferred to Pusan National University Hospital after PTBD, 10 because of incomplete medical records, and six because of insufficient follow-up duration (<4 weeks after PTCS; Fig. 1 ). Patients who had undergone postoperative 
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Clinical information was collected through a retrospective review of medical records. The study protocol was reviewed and approved by the Institutional Review Board of the Pusan National University Hospital (H-1910-004-083).
Preparation for cholangioscopy
Thirty minutes before the procedure, empirical antibiotics (2nd generation cephalosporin) were administered to patients for the prevention of cholangitis and other infections. If necessary, fresh frozen plasma, platelet concentrate, and/or packed red blood cells were transfused. PTBD was performed using an 8. 
Definition of complications
The PTCS procedure is completed in four stages: 1) PTBD, 
Estimation of risk factors
Statistical analysis
Patients with complications and those without complications were compared using the t-test or Chi-squared test and logistic regression analysis. Among the patients who underwent serial tract dilatations, differences between those who experienced complications and those who did not were evaluated using the Chi-squared test or Fisher's exact test. Patients were analyzed according to the number of tract dilatation sessions (2 vs. ≥3 session) and the tract dilatation interval (≤3 days vs. >3 days).
Statistical calculations were performed using SPSS version 21.0 for Windows (SPSS, Chicago, IL, USA). Results were considered statistically significant when the p-value was <0.05. 
RESULTS
Baseline clinical data
PTCS-related complications
Of the 212 patients who underwent all PTCS stages, 32 (15.1%) developed complications: during the preparatory stage in 20 patients (9.4%) and during the PTCS stage (total of 598 sessions) in 12 patients (5.7%, 2.0% per PTCS session). The incidence of complications according to the number of sessions was not statistically different, but tended to be high at first (1st Values are presented as median (interquartile range) or number (%). Table 2) .
None of the patients died. 
Risk factors for complications
DISCUSSION
The overall incidences of complications and mortality rates associated with PTCS have been reported to be 6-17% and 0-0.6%, respectively, in previous studies. 6, 7, [11] [12] [13] [14] In the current study, the incidence of complications during the entire PTCS procedure was 15.1% and there were no deaths. The incidence of complications was higher during the preparatory stage than during the PTCS sessions (9.4% vs. 5.7%). In other, previous studies, complications have also been found to occur more frequently during the preparatory stage (including PTBD, tract dilatation, and tract maturation) than during the PTCS stage. 5, 10, 11, 15 Accordingly, our findings agree with the results of previous studies. In the current study, however, complications were not categorized as mild or severe because of the ambiguity of this definition.
The incidence of complications per PTCS session was 2.0% in our study. One other study reported an incidence or 6.9%
(58/848 sessions), making our results quite low by comparison. 11 This difference could be explained by the higher proportion of cases with serial tract dilatations (≥2 sessions, 44.8% vs. 1.8%) and the longer tract maturation time (mean: 14.3 days vs. 9.5
days) in the current study. 11 Many other centers have reported the use of serial dilatation and long maturation times to minimize complications. [6] [7] [8] [9] [10] In our study, complications occurred less frequently in patients who underwent serial tract dilatations (10.5%, 0.5% per PTCS session), although the difference was not statistically significant (p=0.094).
Furthermore, maturation time did not affect the rate of complications (p =0.214). Common PTCS-related complications include hemobilia, cholangitis, and biliary tract perforations. In our study, cholangitis, bile duct injury, and hemobilia were the common complications. Cholangitis occurred more frequently during the preparatory stage than during the PTCS stage (10 cases vs. four cases), but bile duct injury was more common during the PTCS stage (two cases vs. four cases).
Pancreatitis occurred during the preparatory stage in two cases.
Although significant pain had been a common complication in some previous studies, this was well controlled by analgesic use in our study and did not prolong hospitalization or warrant the use of additional interventions. 11, 13 It is also noteworthy that, in contrast to earlier studies, we did not focus on any particular disease, and our findings therefore provide a more representative and generalized picture of PTCS.
Of the investigated patient characteristics, age was the only significant independent risk factor. Comorbidities generally become more common with increasing age, so this finding is not unexpected. Nonetheless, our study provides the first statis- sessions) was an independent factor for predicting the PTCS-related complications rate. We considered that several biliary tract dilatations using Foley catheters in a stepwise manner could have decreased the incidence of complications in our study. To verify the relationship between the tract dilatation interval and the risk of complications, a subgroup analysis was performed for patients with a serial tract dilatation. We found that an interval of ≤3 days was associated with a higher complication rate.
In a previous study, complications and mortality were significantly reduced by dilatation of the biliary tract in two sessions with a 3-day interval, followed by tract maturation for 6 days. 10 However, that study only enrolled a small group of patients, and the enrolled patients had only undergone EHL for common bile duct or intrahepatic duct stones. Accordingly, the factors that influenced the results (e.g., number of dilatation sessions, tract dilatation interval, and tract maturation time)
could not be determined. In our study, we sought to determine which specific factors affected the incidence of complications, and therefore analyzed each factor's relationship with rapid tract dilatation and tract maturation time. Our result will be helpful for the creation of a preparatory protocol.
In a previous study, EHL or balloon dilatation was associated with the incidence of complications and the complication rate was higher during the first session of PTCS than during the second or subsequent sessions. 11 On the other hand, PTCSrelated procedures (such as EHL and balloon dilatation) did not affect the incidence of PTCS-related complications in the present study. Further, of the 12 patients who developed complications at the PTCS stage, complications had only occurred in seven patients after the first session. Nevertheless, the study group was small and the results were not statistically significant. Moreover, the access hepatic duct (right anterior, right posterior, or left lateral), procedure type (diagnostic or therapeutic), and number of PTCS sessions did not affect the complication rate, either.
Our study involved only a single center and had the retrospective nature. It could have introduced some selection bias.
However, because the procedure was performed by only two experienced endoscopists and radiologists, technique-related bias was minimized. Furthermore, relatively more patients were enrolled than in previous studies. 7, 10, 17 In conclusion, although PTCS is relatively safe, complications can occur at each stage.
Patient age and CT findings should be considered to determine the risk of complications. Furthermore, stepwise preparation may help to control the number of tract dilatations and the interval between tract dilatations may help to reduce the risk of complications. Careful preparation is essential in high-risk groups of patients who are older or who have liver cirrhosis or non-dilated intrahepatic ducts on CT. We recommend three or more stepwise tract dilatations and a long interval between tract dilatations (>3 days) in these groups.
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